Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITDAEPS (Basic)EPS (Weighted Average and Diluted)Interest & Investment IncomeInterest ExpensesInterest ExpensesNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Achieve Life Sciences (ACHV) Shares Outstanding (2016 - 2026)

Achieve Life Sciences (ACHV) has disclosed Shares Outstanding for 17 consecutive years, with $53.2 million as the latest value for Q1 2026.

  • Quarterly Shares Outstanding rose 53.5% to $53.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $53.2 million through Mar 2026, up 53.5% year-over-year, with the annual reading at $53.2 million for FY2025, 53.48% up from the prior year.
  • Shares Outstanding for Q1 2026 was $53.2 million at Achieve Life Sciences, roughly flat from $53.2 million in the prior quarter.
  • The five-year high for Shares Outstanding was $53.2 million in Q1 2026, with the low at $9.5 million in Q1 2022.
  • Average Shares Outstanding over 5 years is $30.0 million, with a median of $34.3 million recorded in 2024.
  • The sharpest move saw Shares Outstanding soared 117.99% in 2023, then rose 1.26% in 2025.
  • Achieve Life Sciences' Shares Outstanding stood at $17.9 million in 2022, then increased by 18.26% to $21.2 million in 2023, then surged by 63.87% to $34.7 million in 2024, then surged by 53.48% to $53.2 million in 2025, then grew by 0.01% to $53.2 million in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Shares Outstanding are $53.2 million (Q1 2026), $53.2 million (Q4 2025), and $52.8 million (Q3 2025).